Project Title: Preventing African new born and children's deaths through proactive patient management
Project Description: More than 5 million newborns and children die each year from conditions which are treatable at low costs. Treatment comes too late due to staff shortage and lack of suitable medical equipment to monitor and manage these children in-time. To address this challenge GOAL3 developed a tablet-assisted patient monitoring system: the IMPALA system. It consists of a vital signs monitoring device that is connected to a supportive application through a central GOAL3 server. The monitoring... More than 5 million newborns and children die each year from conditions which are treatable at low costs. Treatment comes too late due to staff shortage and lack of suitable medical equipment to monitor and manage these children in-time. To address this challenge GOAL3 developed a tablet-assisted patient monitoring system: the IMPALA system. It consists of a vital signs monitoring device that is connected to a supportive application through a central GOAL3 server. The monitoring device has a pulse oximeter, ECG electrodes, non-inasive blood pressure sensor and a temperature sensor. The application enables health workers to rapidly interpret data and improve work processes. IMPALA is currently used in the EU-funded IMPALA clinical cohort in Malawi. An additional 2 implementations are planned in Malawi Rwanda. GOAL3 will provide value-added data-driven services complementary to the IMPALA system to ensure a high uptime, consistent use of the system and continuous quality of care improvement. The system will be provided as a service in a flexible up-front/subscription model. This ensures financial accessibility while enabling us to monitor and improve the products and services over time. The market opportunity is large with more than 5,000 hospitals in Sub-Saharan Africa with an average of 30 ICU/critical care beds, resulting in an addressable market of>150.000 systems. Within this VAP, we will assess the technological, market and compliance feasibility of our patient monitoring solution together wiht the Ifakara Health Institute and the Sengerema Council District Hospital. Technological co-creation and uptake include an analysis of the regulatory framework and novel technology verification. In addition, a small-scale demonstration project at the SCDH will assess the fit with local needs and act as a reference site for stakeholders. Furthermore, we will identify and select local partners needed for distribution, implementation, and sales after this VAP. To assess the market feasibility, we will perform qualitative and quantitative market research, a competitor analysis, and product commercial research. After this VAP we will co-develop the system in a research project together with IHI. This will include the development of data-driven services and cost-effectiveness analysis.
Principal Investigator : Donat Shamba
Department Name :
Time frame: (2023-04-20) - (2023-10-31)
The University of Birmingham (Normal)
GOAL3 (Normal)
External Collaborating Partners
None added yet.